Conjunctivitis, or inflammation of the conjunctiva, is a general term that refers to a diverse group of diseases/disorders that affect the conjunctiva primarily. Most varieties of conjunctivitis are self-limited, but some progress and may cause serious ocular and extraocular complications.
The technical barriers of conjunctivitis industry are existed apparently. The key technology and higher level products are in the hand of the global leading enterprise like Novartis, Santen Pharmaceutical, Bausch + Lomb, Allergan, Sun Pharmaceutical, Akorn, Sinqi, etc.
The unmet need for viral conjunctivitis is the key driver for the growth of this market. Since there are no approved drugs for the treatment of viral conjunctivitis, many companies and researchers are now developing drugs that are in the clinical stage of development. These drugs are expected to aid in the treatment of viral conjunctivitis and their effectiveness will in turn promote growth in this market in the next four years.
According to this study, over the next five years the Conjunctivitis market will register a 1.7% CAGR in terms of revenue, the global market size will reach US$ 3690 million by 2024, from US$ 3330 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Conjunctivitis business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Conjunctivitis market by product type, application, key manufacturers and key regions and countries.
This study considers the Conjunctivitis value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Antibiotic
Pills
Ointment
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
Newborns
Children
Adults
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Allergan, Inc
Merck
Pfizer, Inc.
Novartis
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Conjunctivitis consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Conjunctivitis market by identifying its various subsegments.
Focuses on the key global Conjunctivitis manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Conjunctivitis with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Conjunctivitis submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
